ArticleExperimental hematology & oncology2025

Reduced morbidity and mortality of cGVHD in patients who received treatment with mesenchymal stromal cells for steroid-resistant aGVHD: long-term follow-up of a randomized phase 3 trial.

Ke Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.